Western blotting revealed that the ATG7 level was decreased in 3 × Tg-AD mice, but increased with AAV-NF-α1/CPE or AAV-NF-α1/CPE-E342Q treatment (Fig. 7d). Here, ATG7 is linked to Alzheimer disease.